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Abstract
Objectives—The goal of this randomized controlled pilot study was to determine whether Life
Goals Collaborative Care (LGCC) compared to enhanced treatment as usual, reduced
cardiometabolic factors and improved outcomes for persons with bipolar disorder from
community-based practices.
Methods—Persons were randomized to receive LGCC (N=32) or enhanced treatment as usual
(N=33). LGCC included four weekly self-management sessions and telephone contacts to
encourage provider engagement and measurement-based care; enhanced treatment as usual
included wellness mailings. Outcomes were body mass index-BMI, blood pressure, quality of life,
functioning, and symptoms.
Results—Compared to enhanced treatment as usual, LGCC was not associated with reduced
cardiometabolic risk factors based on 6 and 12-month repeated measures analyses. Among
patients with BMI >=30 or systolic blood pressure >=140, LGCC was associated with decreased
impaired functioning (respectively beta=−2.2, beta=−3.8;p=.04 for both) and depressive symptom
scores (respectively beta=−2.0, beta=−3.5;both p=.04).
Conclusions—LGCC may improve outcomes among patients with elevated baseline
cardiometabolic risk from community-based practices.
Keywords
Mood disorders bipolar; cardiovascular disease; self-management; recovery
BACKGROUND
Mental disorders are associated with premature mortality, primarily from cardiovascular
disease (1). Cardiometabolic indicators, notably obesity, are key drivers of cardiovascular
disease, which can be exacerbated by psychiatric symptoms such as depression and
unhealthy behaviors including physical inactivity, overeating, and tobacco use (2).
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As one of the most expensive mental disorders in the U.S. (3), bipolar disorder affects up to
6.4% of the U.S. population (4) and is characterized by alternating manic/depressive
episodes that can lead to non-adherence, disrupted continuity of care, and elevated
cardiometabolic risk (5). Many persons with bipolar or other mental disorders receive care
from community-based mental health programs with limited access to medical care (6).
To date most programs that target cardiometabolic risk in mental disorders have primarily
been implemented for unipolar depression (7) or involved intensive behavioral interventions
(8). With the increasing focus on value-based care, practical interventions that address
multiple cardiometabolic risk factors and can be taught to existing providers are desired by
community-based providers.
Collaborative/chronic care models (9–10) potentially address multiple cardiometabolic risk
factors among patients with mental disorders (7). These models usually consist of patient
education on disease self-management, ongoing coordination of medical and mental health
care by a non-physician interventionist, and ongoing symptoms monitoring (measurement-
based care), and represent a core component of the emerging health home models in
Medicaid programs (11). However, there has been limited implementation of chronic care
models in community-based mental health programs, and none that have focused on bipolar
disorder.
The goal of this pilot study is to determine whether a Chronic Care Model, Life Goals
Collaborative Care (LGCC) compared to enhanced treatment as usual reduces
cardiometabolic risk factors and improves outcomes for patients with bipolar disorder.
METHODS
This randomized controlled effectiveness trial compared LGCC to enhanced treatment as
usual and enrolled patients diagnosed with bipolar disorder and had at least one
cardiometabolic risk factor. The study was reviewed and approved by the University of
Michigan Medical School Institutional Review Board.
Patients >=18 years from two community-based mental health outpatient programs in
Southeastern Michigan were recruited in 2009 and randomized to receive LGCC or
enhanced treatment as usual. Patients were included if they had an active diagnosis or
treatment plan for Bipolar I, Bipolar II, or Bipolar NOS based on chart review; had at least
one cardiometabolic risk factor (diagnosis or indication of hypertension, hyperlipidemia,
diabetes, or BMI >25 based on medical record review), were community-dwelling, and
English-speaking. Patients were excluded if they had severe cognitive impairment or were
unable to give informed consent.
After a survey coordinator confirmed eligibility, patients provided informed consent and
completed a clinical exam (weight, height, and two blood pressure measures) and a self-
completed survey. Participants were compensated $10 for each assessment. A chart review
was also conducted to ascertain utilization information. The data analyst then randomized
participants to LGCC or enhanced treatment as usual in blocks of 16–20 stratified by age,
race, and diabetes diagnosis in order to ensure balance of these characteristics. The survey
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coordinator was blinded to randomization of patient assignment. Those randomized to
LGCC were contacted by the study interventionist within two weeks to schedule
intervention sessions.
LGCC intervention details are described elsewhere (12). In brief, the MSW-level
interventionist provided four 2-hour weekly group self-management sessions, followed by
brief care management contacts to patients randomized to LGCC for up to 6 months. Each
group session included approximately 8–10 participants, and sessions were based on social
cognitive theory. The sessions included active discussions by patients that were focused on
their personal goals, and alignment of those goals with healthy behavior changes and action
planning to cope with current symptoms. Specific focus points covered throughout the four
sessions included bipolar disorder and cardiovascular disease risk, stigma issues, wellness
habits including diet and exercise within the context of symptom coping strategies, and
collaborative care management.
After the group sessions, the interventionist made brief (20-minute), individualized
telephone or in-person contacts to patients over a 6-month period to track symptoms as well
as progress towards wellness goals using motivational enhancement techniques. The
interventionist tracked patient symptoms and health goals using an electronic registry over
the 6-month period and alerted providers regarding medical or mental health needs.
The interventionist underwent a 2-day training program developed by the investigators and
followed a standardized set of protocols and intervention manual. Fidelity was measured
using a combination of direct observation of a random sample of Life Goals group sessions
and reviews of interventionist logs. Key fidelity indicators included number of group
sessions completed by the patient, number of focus points covered by the interventionist in
the sessions, and number of follow-up contacts.
Enhanced TAU included monthly receipt of mailings on wellness topics over the course of
the 6-month LGCC intervention period in addition to available mental health care, and
referral to primary care services off-site.
Outcomes included cardiometabolic risk (body mass index-BMI, systolic/diastolic blood
pressure), health-related quality of life (SF-12) (12), functioning (World Health
Organization Disability Assessment Scale) (13), and psychiatric symptoms (Internal State
Scale) (14)
Statistical analyses ascertaining the effect of LGCC versus enhanced treatment as usual were
considered exploratory as this was a pilot study. Repeated measures analyses were used to
determine the effect of LGCC versus enhanced treatment as usual on outcomes and
utilization.
RESULTS
Out of 118 patients approached, 12 were ineligible due to not having a confirmed bipolar
diagnosis, 13 were ineligible due to not having a cardiometabolic risk factor, and 25
declined to participate. There were no significant differences among those who declined
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versus those who were enrolled. Of the 68 enrolled, 34 were randomized to LGCC and 34 to
enhanced treatment as usual. Overall, 65 completed 6 and 12-month assessments. The mean
age was 45±13, with 61% female, and 19% African-American (Table 1). The majority of
participants had elevated cardiometabolic risk factors at baseline, notably hypertension, high
BMI, and diabetes. Twenty-six percent had a current prescription for a mood stabilizer, and
11% for an atypical antipsychotic medication (Table 1).
Among the LGCC group, 26 (79%) completed >=3 self-management sessions, the
interventionist covered >80% of session focus points, and the mean number of follow-up
contacts completed was 4.5±1.5 out of 6. The mean number of contacts to providers made
by interventionists for each patient was 2.2±1.8 during the 6-month follow-up period.
Repeated measures analyses (Table 2) found that LGCC compared to enhanced treatment as
usual was not associated with reduced cardiometabolic risk factors or improved health-
related quality of life. Only the effects of LGCC on reduced impaired functioning and on
depressive symptoms approached significance, with effect sizes of, respectively, .20 and .23.
In a repeated measures post-hoc analysis in which the sample was limited to those with
elevated cardiometabolic risk, those with BMI >=30 or systolic blood pressure of >=140 in
the LGCC compared to the enhanced treatment as usual group had decreased impaired
functioning (respectively beta=−2.2, beta=−3.8; both p=.04) and depressive symptom scores
(respectively beta=−2.0, beta=−3.5; both p=.04) (See Appendix). However, after Bonferoni
adjustment, these findings are not statistically significant. Further, we conducted a
multifactorial analysis with treatment and groups as factors included in the repeated measure
multivariate regression models, and test the interactions between treatment and groups. The
results showed a significant interaction between treatment and SBP>=140 groups(beta for
the interaction=−4.1, p=0.02), indicating the LGCC decreased impaired functioning more so
in the SBP>=140 group than the SBP<140 group; however, there was no interactions
between the treatment and BMI>=30 groups in the impaired functioning model, and no
significant interactions were found in the depression symptom model. Wherein these post-
hoc analyses are for exploratory purpose, the significant interactions between the treatment
and SBP>=140 warrants further investigations on what characteristics-bearing groups may
benefit the most out of the LGCC intervention.
There were no significant differences in utilization between the LGCC and enhanced
treatment as usual groups over the 12-month study period, and 40% of the overall sample
received diet and wellness group sessions apart from LGCC (See Appendix).
DISCUSSION
Compared to enhanced treatment as usual, LGCC was not associated with reduced
cardiometabolic risk factors or other patient outcomes. However, among patients with
elevated cardiometabolic risk, LGCC resulted in reduced impaired functioning and
depressive symptoms.
LGCC was designed to be cost-efficient, emphasizing patient self-management, and care
management was limited to communication with clinicians as opposed to medication
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management. Available medical care was off-site, which may have impeded access to
cardiometabolic risk factor management. Katon et al. (7) found that the chronic care model
led to reduced cardiometabolic risk primarily through medical care management for patients
with substantial medical burden. In contrast, LGCC involved four 2-hour self-management
sessions and limited follow-up contacts with providers, which may have had limited impact
on cardiometabolic risk in our sample. Our target population included those with a wider
range of cardiometabolic risk factors, which may have led to little room for improvement in
outcomes. Moreover, “usual care” in our community mental health programs included group
wellness sessions which might have mitigated any differences in cardiometabolic risk in the
LGCC group.
Nonetheless, LGCC improved outcomes for patients with elevated cardiometabolic risk
(high BMI or elevated blood pressure), notably reduced impaired functioning and depressive
symptoms. Previous studies of the chronic care model for bipolar disorder did not find
significant reductions in depression (15). Perhaps LGCC’s focus on health behavior
strategies had a positive effect on depression and functioning. Reducing depressive
symptoms and functional impairment could also be initial steps in ultimately reducing
cardiometabolic risk, by mitigating barriers to self-management strategies such as exercise.
Interventions that focus on improved functioning are also important given that they help
with recovery-oriented goals such as employment and relationships.
The elevated risk of mortality due to cardiovascular disease has been well-recognized
among persons with mental disorders (2). To date there have been few effective
interventions to improve outcomes in this group that are also practical to implement in
community-based settings. Recognizing the mortality gap due to cardiovascular disease
among persons with mental disorders, community-based mental health programs have
advocated for integrated general medical services. The Substance Abuse and Mental Health
Services Administration funded several demonstration programs focused on improving
medical outcomes among patients seen in community mental health programs. The
Affordable Care Act has also proposed health home models that reimburse medical care for
persons with mental disorders. Still, these initiatives have not specified the types of services
that should be provided, or how to integrate and reimburse for components of the chronic
care model such as self-management.
Limitations of this study included the relatively small sample size and lack of formal
diagnostic assessment for bipolar disorder. The limited use of care management beyond the
group sessions may have explained the limited impact of LGCC on long-term
cardiometabolic risk. Only a fraction of participants had complete lab data (e.g., lipids,
glucose), which may have reflected inadequate access to medical care, and we were unable
to specify the types of medical care provided. As some mental health providers likely had
patients from both study conditions, the contacts they received from the interventionists may
have also affected the likelihood that they would apply more careful cardiometabolic
monitoring to those in the enhanced treatment as usual group. Finally, the study’s findings
may not generalize to settings outside of Southeastern Michigan.
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Nonetheless, as a relatively brief intervention emphasizing self-management, LGCC may
lead to increased daily, social, and occupational functioning and reduced depressive
symptoms among the most medically vulnerable. Ultimately, psychosocial interventions
such as LGCC have potential to improve outcomes that are consistent with recovery-
oriented care, and can inform the emerging medical home models for persons with mental
disorders. Further research is needed to determine whether LGCC can impact
cardiometabolic risk factors across a broad group of individuals with mental disorders, either
through enhanced self-management over the long term and/or through more intensive
medical care management. Whether LGCC can be applied to improve cardiometabolic
outcomes in other treatment settings such as primary care would also be helpful in further
tailoring these programs to help the most vulnerable.
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